{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:25:59Z","timestamp":1791516359241,"version":"4.3.4"},"reference-count":53,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:00:00Z","timestamp":1758931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Crohn\u2019s disease (CD) is an inflammatory bowel disease (IBD) that is prevalent worldwide. It can affect any segment of the gastrointestinal tract, from the mouth to the anus. When CD affects the anus, perianal fistulizing disease develops. The management of perianal CD is challenging and may require morbid surgery when there is no response to medical therapy. The emergence of novel biologic therapies, namely tumor necrosis alpha (TNF-\u03b1) inhibitors, has proven to provide long-term relief and prevent disease-related complications. Perianal CD is, however, refractory or recurrent in up to 80% of patients. One of the reported options to manage perianal CD is hyperbaric oxygen therapy (HBOT), which aims at increasing tissue oxygen saturation in an attempt to promote repair and reverse local inflammation. Data on this approach is scant. Methods: A retrospective review was performed to identify patients with CD at the Mayo Clinic in Rochester who underwent HBOT for perianal disease between 2014 and 2023. Demographic and clinical data were reviewed, including the history of the disease, concomitant medical and surgical therapy and the need for fecal diversion. The HBOT regimen, including the number of sessions and clinical response, were reviewed. Results: Six patients aged from 19 to 60 years underwent HBOT for perianal CD. Two patients had a history of total proctocolectomy with ileal-anal pouch anastomosis (IPAA). All patients except one were on immunosuppressive medication including biologic agents. Four patients had fecal diversion with an ileostomy or colostomy. Patients received between 10 and 40 sessions of HBOT. Four patients reported symptomatic improvement. On physical examination and\/or imaging assessment, improvement was noted in one patient. Progression of the perianal disease was noted in all other patients, with all except one requiring an operation in the following year. Conclusions: HBOT may provide symptomatic relief in some patients with refractory perianal CD, but data on its long-term efficacy remains limited.<\/jats:p>","DOI":"10.3390\/jcm14196843","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:01:39Z","timestamp":1759154499000},"page":"6843","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hyperbaric Oxygen Therapy in the Management of Refractory Perianal Crohn\u2019s Disease"],"prefix":"10.3390","volume":"14","author":[{"given":"Roy","family":"Hajjar","sequence":"first","affiliation":[{"name":"Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN 55904, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Bews","sequence":"additional","affiliation":[{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN 55904, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Amine","family":"Alaoui","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN 55904, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidrah","family":"Khan","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN 55904, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Gleason","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN 55904, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Sanchez","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN 55904, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8790-2538","authenticated-orcid":false,"given":"Ian S.","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN 55904, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunanda V.","family":"Kane","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55904, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Perry","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN 55904, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kellie L.","family":"Mathis","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN 55904, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas P.","family":"McKenna","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN 55904, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.3748\/wjg.v12.i38.6102","article-title":"Recent trends in the epidemiology of inflammatory bowel diseases: Up or down?","volume":"12","author":"Lakatos","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1053\/j.gastro.2023.07.003","article-title":"Incidence, Prevalence, and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States","volume":"165","author":"Lewis","year":"2023","journal-title":"Gastroenterology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.crohns.2013.09.009","article-title":"A tale of two diseases: The history of inflammatory bowel disease","volume":"8","author":"Mulder","year":"2014","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41586-025-08940-0","article-title":"Global evolution of inflammatory bowel disease across epidemiologic stages","volume":"642","author":"Hracs","year":"2025","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/ibd\/izz076","article-title":"Challenges in IBD Research: Environmental Triggers","volume":"25","author":"Ho","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"98526","DOI":"10.4240\/wjgs.v17.i3.98526","article-title":"Genetic and environmental factors influencing Crohn\u2019s disease","volume":"17","author":"Fan","year":"2025","journal-title":"World J. Gastrointest. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1136\/gutjnl-2021-326257","article-title":"Immunopathogenesis and environmental triggers in coeliac disease","volume":"71","author":"Levescot","year":"2022","journal-title":"Gut"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/gut.52.4.552","article-title":"Early development of stricturing or penetrating pattern in Crohn\u2019s disease is influenced by disease location, number of flares, and smoking but not by NOD2\/CARD15 genotype","volume":"52","author":"Louis","year":"2003","journal-title":"Gut"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/ibd\/izac162","article-title":"Patients With Stricturing or Penetrating Crohn\u2019s Disease Phenotypes Report High Disease Burden and Treatment Needs","volume":"29","author":"Fan","year":"2023","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ibd.21099","article-title":"Incidence of stricturing and penetrating complications of Crohn\u2019s disease diagnosed in pediatric patients","volume":"16","author":"Gupta","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-0041-1729926","article-title":"Crohn\u2019s Disease Obstructions","volume":"34","author":"Ford","year":"2021","journal-title":"Clin. Colon. Rectal Surg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/2050640613487194","article-title":"Fistulizing Crohn\u2019s disease: Diagnosis and management","volume":"1","author":"Gecse","year":"2013","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Wetwittayakhlang, P., Al Khoury, A., Hahn, G.D., and Lakatos, P.L. (2022). The Optimal Management of Fistulizing Crohn\u2019s Disease: Evidence beyond Randomized Clinical Trials. J. Clin. Med., 11.","DOI":"10.3390\/jcm11113045"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cgh.2023.08.017","article-title":"Comparative Effectiveness of Biologic Therapies in Preventing Penetrating Complications in Patients With Crohn\u2019s Disease","volume":"22","author":"McCurdy","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"otae065","DOI":"10.1093\/crocol\/otae065","article-title":"Clinical Course of Isolated Recurrent, Persistent Complex Perianal Fistulas Without Luminal Crohn\u2019s Disease: A Multicenter Case Series of 24 Patients","volume":"6","author":"Fiske","year":"2024","journal-title":"Crohn\u2019s Colitis 360"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/ibd\/izab287","article-title":"Epidemiology and Natural History of Perianal Crohn\u2019s Disease: A Systematic Review and Meta-Analysis of Population-Based Cohorts","volume":"28","author":"Tsai","year":"2022","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"American Gastroenterological Association (2003). American Gastroenterological Association medical position statement: Perianal Crohn\u2019s disease. Gastroenterology, 125, 1503\u20131507.","DOI":"10.1016\/S0016-5085(03)01060-6"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-0039-1683907","article-title":"Management of Complex Anorectal and Perianal Crohn\u2019s Disease","volume":"32","author":"Bolshinsky","year":"2019","journal-title":"Clin. Colon. Rectal Surg."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Mutlu, A.U., Unal, H.U., Gulmez, M., Saracoglu, C., Aytac, E., and Saruc, M. (2025). Surgical Management of Perianal Crohn\u2019s Disease with the Turnbull-Cutait Procedure: A Case Report. Life, 15.","DOI":"10.3390\/life15030460"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Hahn, G.D., Golovics, P.A., Wetwittayakhlang, P., Al Khoury, A., Bessissow, T., and Lakatos, P.L. (2022). Is There a Best First Line Biological\/Small Molecule in IBD: Are We Ready for Sequencing?. Biomedicines, 10.","DOI":"10.3390\/biomedicines10040749"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.3748\/wjg.v27.i25.3693","article-title":"Approach to medical therapy in perianal Crohn\u2019s disease","volume":"27","author":"Vasudevan","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/ibd\/izz051","article-title":"Refractory Complex Crohn\u2019s Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection","volume":"26","author":"Laureti","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Colombo, F., Cammarata, F., Baldi, C., Rizzetto, F., Bondurri, A., Carmagnola, S., Gridavilla, D., Maconi, G., Ardizzone, S., and Danelli, P. (2022). Stem Cell Injection for Complex Refractory Perianal Fistulas in Crohn\u2019s Disease: A Single Center Initial Experience. Front. Surg., 9.","DOI":"10.3389\/fsurg.2022.834870"},{"key":"ref_25","first-page":"227","article-title":"Hyperbaric Oxygen Therapy for Refractory Perianal Crohn\u2019s Disease: A Case Report","volume":"20","author":"Tome","year":"2024","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/0016-5085(89)90649-5","article-title":"Healing of severe perineal and cutaneous Crohn\u2019s disease with hyperbaric oxygen","volume":"97","author":"Brady","year":"1989","journal-title":"Gastroenterology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2147\/IJGM.S172460","article-title":"Hypoxia and hyperbaric oxygen therapy: A review","volume":"11","author":"Choudhury","year":"2018","journal-title":"Int. J. Gen. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.clinthera.2023.06.013","article-title":"Persistence Among Patients with Crohn Disease Previously Treated with an Anti-tumor Necrosis Factor Inhibitor and Switching or Cycling to Another Biologic Agent","volume":"45","author":"Zhdanava","year":"2023","journal-title":"Clin. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/gutjnl-2022-328389","article-title":"Gut microbiota influence anastomotic healing in colorectal cancer surgery through modulation of mucosal proinflammatory cytokines","volume":"72","author":"Hajjar","year":"2023","journal-title":"Gut"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.micinf.2016.09.004","article-title":"Hypoxia and inflammatory bowel disease","volume":"19","author":"Cummins","year":"2017","journal-title":"Microbes Infect."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Dvornikova, K.A., Platonova, O.N., and Bystrova, E.Y. (2023). Hypoxia and Intestinal Inflammation: Common Molecular Mechanisms and Signaling Pathways. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032425"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"goae030","DOI":"10.1093\/gastro\/goae030","article-title":"Hypoxia, hypoxia-inducible factors and inflammatory bowel diseases","volume":"12","author":"Hou","year":"2024","journal-title":"Gastroenterol. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40348-016-0030-1","article-title":"The role of hypoxia in intestinal inflammation","volume":"3","author":"Shah","year":"2016","journal-title":"Mol. Cell. Pediatr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/s41390-024-03569-7","article-title":"Gut microbiome and inflammation in response to increasing intermittent hypoxia in the neonatal rat","volume":"97","author":"Latkowska","year":"2025","journal-title":"Pediatr. Res."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Kim, Y.I., Yi, E.J., Kim, Y.D., Lee, A.R., Chung, J., Ha, H.C., Cho, J.M., Kim, S.R., Ko, H.J., and Cheon, J.H. (2020). Local Stabilization of Hypoxia-Inducible Factor-1alpha Controls Intestinal Inflammation via Enhanced Gut Barrier Function and Immune Regulation. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.609689"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41467-017-00213-3","article-title":"Hypoxia ameliorates intestinal inflammation through NLRP3\/mTOR downregulation and autophagy activation","volume":"8","author":"Simmen","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jcmgh.2017.09.005","article-title":"Hypoxia in the Gut","volume":"5","author":"Taylor","year":"2018","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-0034-1366974","article-title":"Update on middle ear barotrauma after hyperbaric oxygen therapy-insights on pathophysiology","volume":"18","author":"Lima","year":"2014","journal-title":"Int. Arch. Otorhinolaryngol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Zhou, Y., Jia, Y., Wang, T., and Meng, D. (2023). Adverse effects of hyperbaric oxygen therapy: A systematic review and meta-analysis. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1160774"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"i1701","DOI":"10.1093\/ecco-jcc\/jjae190.1074","article-title":"P0900 Hyperbaric oxygen therapy downstages refractory perianal fistulizing Crohn\u2019s disease and allows for surgical closure","volume":"19","author":"Mulders","year":"2025","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_41","first-page":"321","article-title":"The effects of hyperbaric treatment on perianal fistula activity in patients with Crohn\u2019s disease","volume":"19","author":"Piotrowicz","year":"2024","journal-title":"Prz. Gastroenterol."},{"key":"ref_42","first-page":"e62987","article-title":"Hyperbaric Oxygen Therapy Achieved Fistula Healing in a Young Patient With Severe Refractory Perianal Crohn\u2019s Disease","volume":"16","author":"Leong","year":"2024","journal-title":"Cureus"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ueg2.12189","article-title":"Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn\u2019s disease: Results of the HOT-TOPIC trial after 1-year follow-up","volume":"10","author":"Lansdorp","year":"2022","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/apt.16228","article-title":"Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn\u2019s disease","volume":"53","author":"Lansdorp","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6628142","DOI":"10.1155\/2021\/6628142","article-title":"Adjunctive Hyperbaric Oxygen Therapy in Refractory Crohn\u2019s Disease: An Observational Study","volume":"2021","author":"Feitosa","year":"2021","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1177\/2050640620934915","article-title":"Wound healing of metastatic perineal Crohn\u2019s disease using hyperbaric oxygen therapy: A case series","volume":"8","author":"Lansdorp","year":"2020","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1016\/j.dld.2017.09.051","article-title":"Hyperbaric oxygen therapy is an effective adjunctive treatment for severe perianal Crohn\u2019s disease","volume":"49","author":"Bosa","year":"2017","journal-title":"Dig. Liver Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"S373","DOI":"10.1093\/ecco-jcc\/jjx002.700","article-title":"P576 Could the hyperbaric oxygen therapy be an effective adjuvant therapy for fistulising Crohn\u2019s disease?","volume":"11","author":"Piotrowicz","year":"2017","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1590\/S0102-86502016001300005","article-title":"Adjunctive Hyperbaric Oxygen Therapy promotes successful healing in patients with refractory Crohn\u2019s disease","volume":"31","author":"Feitosa","year":"2016","journal-title":"Acta Cir. Bras."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"FSO77","DOI":"10.4155\/fso.15.77","article-title":"Combining infliximab, anti-MAP and hyperbaric oxygen therapy for resistant fistulizing Crohn\u2019s disease","volume":"1","author":"Agrawal","year":"2015","journal-title":"Future Sci. OA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/BF02054120","article-title":"Hyperbaric oxygenation in severe perineal Crohn\u2019s disease","volume":"38","author":"Colombel","year":"1995","journal-title":"Dis. Colon. Rectum"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00004836-199410000-00006","article-title":"Hyperbaric oxygen for perianal Crohn\u2019s disease","volume":"19","author":"Lavy","year":"1994","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/BF01540577","article-title":"Closure of refractory perineal Crohn\u2019s lesion. Integration of hyperbaric oxygen into case management","volume":"35","author":"Nelson","year":"1990","journal-title":"Dig. Dis. Sci."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/19\/6843\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:23:19Z","timestamp":1759155799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/19\/6843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,27]]},"references-count":53,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["jcm14196843"],"URL":"https:\/\/doi.org\/10.3390\/jcm14196843","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,27]]}}}